FASTHEADLINENEWS

$BSX Headlines

12 trading headlines for $BSX

Apr 1 05:40 PM

Boston Scientific (BSX) Says CHAMPION-AF Trial Meets All Primary Endpoints

fdaAlphaVantage

Mar 31 04:13 PM

Abbott Oncology Integration Into OncoEMR Tests Long Term Growth Story

generalAlphaVantage

Mar 30 04:44 PM

Boston Scientific Drops Despite Encouraging Trial Readouts

fdaAlpaca

Mar 30 04:42 PM

RBC Capital Reiterates Outperform on Boston Scientific, Maintains $115 Price Target

analystAlpaca

Mar 30 02:23 PM

This Terns Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday

analystAlpaca

Mar 30 02:15 PM

Raymond James Downgrades Boston Scientific to Outperform, Lowers Price Target to $88

analystAlpaca

Mar 30 11:07 AM

The FDA Grants 510(k) Clearance For Boston Scientific's Asurys Fluid Management System, To Provide Irrigation And Distention During Endoscopic Urologic Procedures

fdaAlpaca

Mar 30 09:55 AM

Needham Reiterates Buy on Boston Scientific, Maintains $97 Price Target

analystAlpaca

Mar 30 07:26 AM

Reported Saturday, Boston Scientific's HI-PEITHO Trial Shows EKOS Endovascular System Superior To Standard Of Care, Delivering 61% Reduction In Primary Endpoint Events In Acute Pulmonary Embolism

fdaAlpaca

Mar 30 07:19 AM

Reported Saturday, Boston Scientific's CHAMPION-AF Trial Of Watchman FLX Device Meets All Primary And Secondary Endpoints, Delivering 45% Relative Reduction In Non-Procedural Bleeding Versus NOAC

fdaAlpaca

Mar 27 05:15 PM

Goldman Sachs Maintains Buy on Boston Scientific, Lowers Price Target to $93

analystAlpaca

Mar 24 10:00 PM

Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

generalYahoo Finance